Efficacy and safety of half‐dose desmopressin for bleeding prophylaxis in bleeding disorder patients undergoing predominantly low to moderate risk invasive procedures
Author:
Affiliation:
1. Department of Internal Medicine Rochester General Hospital Rochester New York
2. Department of Hematology Rochester General Hospital Rochester New York
3. Mary M. Gooley Hemophilia Treatment Center Rochester New York
Publisher
Wiley
Subject
Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25928
Reference6 articles.
1. Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's Disease
2. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders
3. Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients
4. Response to low-dose desmopressin by a subcutaneous route in children with type 1 von Willebrand disease
5. Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: A two decade study
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH;Journal of Thrombosis and Haemostasis;2024-07
2. Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor;Journal of Thrombosis and Haemostasis;2024-06
3. Potential clinical applications of current and future oral forms of desmopressin (Review);Experimental and Therapeutic Medicine;2024-05-29
4. Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease;Blood Coagulation & Fibrinolysis;2023-10
5. Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank;Journal of Thrombosis and Haemostasis;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3